INOVIO to Participate in December Investor Conferences | INO Stock News
INOVIO (NASDAQ:INO), a biotechnology company, announced its participation in December investor conferences. They will attend the Piper Sandler 37th Annual Healthcare Conference on December 2 and the Oppenheimer Movers in Rare Disease Summit on December 11. INOVIO's management will also hold one-on-one meetings with investors. The company focuses on developing DNA medicines for HPV-related diseases, cancer, and infectious diseases.
, /PRNewswire/ --INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines tohelp treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:
Piper Sandler 37th Annual Healthcare Conference (New York, NY)
Date: Tuesday, December 2
Time: 8:30-8:55 AM ET
Format: Fireside Chat
Webcast:https://bit.ly/44af19l (live webcast and replay available for 90 days after the event)
Oppenheimer Movers in Rare Disease Summit (New York, NY)
Date: Thursday, December 11
Time: 12:05-12:25 PM ET
Format: Panel - Elevator Pitches from Rare Disease Companies with Key Near-Term, Potentially Stock-Moving Catalysts
Members of INOVIO's management team will also be conducting one-on-one meetings with investors during these conferences.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505,investor.relations@inovio.com
SOURCE INOVIO Pharmaceuticals, Inc.
